Quite a few insiders have dramatically grown their holdings in OptimizeRx Corporation ( NASDAQ:OPRX ) over the past ...

It is doubtless a positive to see that the OptimizeRx Corporation (NASDAQ:OPRX) share price has gained some 73% in the last three months. But that is small recompense for the exasperating returns ...

OptimizeRx Corporation (NASDAQ: OPRX) Q4 2023 Earnings Conference Call March 28, 2024 8:30 AM ET Company Participants William Febbo - CEO Edward Stelmakh - Chief Financial and Operating Officer ...

OptimizeRx Corp. has appointed Steve Silvestro, currently the Chief Executive Officer, to its Board of Directors effective June 20, 2025.

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today July 22nd: OptimizeRx ...

OptimizeRx Corp. will host a conference call on March 12, 2025, at 8:30 a.m. Eastern Time to discuss its fiscal year 2024 financial results and fourth-quarter results for the period ending ...

WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach ...

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment Provided by GlobeNewswire Apr 18, 2025, 1:15:53 PM ...

OptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET. Company Participants. Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer ...